Abiopharma

PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE YEAR 2026 ENDED MARCH 31, 2026

Ligand Announces Closing of Convertible Senior Notes Offering

NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute

McGrath Second Quarter Earnings and Conference Call Scheduled for July 29, 2026

Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting

Ascendis to Showcase Advances in Treatment of Achondroplasia at ICCBH 2026

Wise Group plc reports Full Year 2026 Financial Results

Truist announces release of 2026 CCAR results

Keros Therapeutics Appoints Anne Prener to its Board of Directors

Salesforce Grants Equity Awards to Momentum Under Its Inducement Equity Incentive Plan